Bicycle Therapeutics plc Gains 24.54%
Fri, Apr 08, 2022 at 05:30 PM
Bicycle Therapeutics plc (BCYC:NASDAQ) jumped higher at $46.99, representing a gain of 24.5%. On Thu, Apr 07, 2022, BCYC:NASDAQ hit a New 2-Week Low of $37.73. The stock got featured on our News Catalysts scanner on Fri, Apr 08, 2022 at 04:34 PM in the 'MISCELLANEOUS' category. From Thu, Mar 24, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About Bicycle Therapeutics plc (BCYC:NASDAQ)
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.
Top 10 Gainers:
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 159.18%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 39.01%
- Bicycle Therapeutics plc (BCYC:NASDAQ), 24.54%
- Poema Global Holdings Corp. (PPGH:NASDAQ), 23.69%
- Lyra Therapeutics, Inc. (LYRA:NASDAQ), 22.22%
- Aterian Inc. (ATER:NASDAQ), 21.3%
- Eastside Distilling, Inc. (EAST:NASDAQ), 20.54%
- Helix Acquisition Corp. (HLXA:NASDAQ), 19.8%
- 9F Inc. (JFU:NASDAQ), 19.79%
- TSR, Inc. (TSRI:NASDAQ), 19.72%